Eseandre Mordi
⬤ Hims & Hers Health posted a sharp after-hours surge, jumping nearly 40% and briefly touching $22. The rally follows a prolonged selloff that dragged HIMS toward the mid-$15 range. Bullish partnership news may be the catalyst needed to reverse a downtrend that has pressured the stock for months.
⬤ The weekly chart tells the full story of the correction. HIMS climbed strongly throughout 2024, peaking near the $50-$60 range, before a steady downtrend of lower highs and lower lows took hold. The price recently touched approximately $15.74. RSI sat near oversold territory and MACD remained negative heading into the rebound, reflecting persistent bearish momentum before the sudden spike.
⬤ Analysts are now watching whether the bounce can evolve into a sustained recovery. Those $27-$31 upside targets correspond to previous consolidation zones and are likely to act as the first meaningful resistance if buyers regain control. During the decline, traders had been closely monitoring critical support around $15 and $25 as decision points for the broader trend.
⬤ The speed of the after-hours move illustrates how fast sentiment can flip in high-volatility growth names. HIMS has spent an extended period in a corrective phase after peaking well above current levels. As previous coverage highlighted, the broader trend has stayed under pressure despite occasional bounces. Should momentum hold and HIMS reclaim former support zones, this latest surge could mark the start of a more meaningful recovery.
Eseandre Mordi
